Next-generation ctDNA-driven clinical trials in precision immuno-oncology
Saved in:
Main Authors: | Charu Aggarwal, Natasha B Leighl |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/1/e006397.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Machine learning-driven insights into ctDNA for oral cancer: Applications, models, and future prospects
by: Dheeraj Kumar, et al.
Published: (2024-09-01) -
Precision oncology through next generation sequencing in hepatocellular carcinoma
by: Sayali Shinde, et al.
Published: (2025-02-01) -
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
by: Martina Ruglioni, et al.
Published: (2025-02-01) -
The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant
by: Stacey A. Cohen, et al.
Published: (2022-01-01) -
Value of ctDNA in surveillance of adjuvant chemosensitivity and regimen adjustment in stage III colon cancer: a protocol for phase II multicentre randomised controlled trial (REVISE trial)
by: Jun Huang, et al.
Published: (2025-01-01)